Relationship between platelet indexes and coronary angiographic findings in patients with ischemic heart disease

Akihiro Ihara1, Toshiharu Kawamoto, Kengo Matsumoto

  • 1Department of Hematology, National Hospital Organization Kure Medical Center, Hiroshima, Japan. a-ihara@kure-nh.go.jp

Insights

Platelet indexes like platelet-large cell ratio (P-LCR) can indicate coronary artery disease risk. Lower P-LCR levels may identify patients with significant coronary artery obstruction, aiding in risk assessment for ischemic heart disease.

Area of Science:

  • Cardiology
  • Hematology
  • Medical Diagnostics

Background:

  • Platelets play a crucial role in thrombosis and cardiovascular events.
  • Understanding platelet behavior is key to managing coronary artery disease (CAD).
  • Platelet indices offer potential biomarkers for cardiovascular risk stratification.

Purpose of the Study:

  • To investigate the relationship between coronary angiographic morphology and various platelet indices.
  • To determine if platelet count, MPV, P-LCR, and PDW correlate with the presence and severity of coronary artery obstruction in ischemic heart disease patients.

Main Methods:

  • Eighty-four ischemic heart disease patients and 120 aged controls were analyzed.
  • Coronary angiography was performed to assess coronary obstruction.
  • Platelet count, mean platelet volume (MPV), platelet-large cell ratio (P-LCR), and platelet distribution width (PDW) were measured from peripheral venous blood.

Main Results:

  • Mean platelet counts were significantly lower in both angiographically positive and negative groups compared to controls.
  • MPV, P-LCR, and PDW were significantly higher in the angiographically negative group compared to both the positive group and controls.
  • Platelet indices in the angiographically positive group were similar to controls, except for platelet count.

Conclusions:

  • Platelet indices can reflect the pathophysiological state and clinical events in patients with ischemic heart disease.
  • A lower P-LCR appears to be a specific indicator for identifying patients with positive coronary angiography findings.
  • These findings suggest the utility of platelet index monitoring in CAD risk assessment.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...